Literature DB >> 8628486

Dose-response curve of human extensor digitorum brevis muscle function to intramuscularly injected botulinum toxin type A.

R R Sloop1, R O Escutin, J A Matus, B A Cole, G W Peterson.   

Abstract

To develop a human model for measuring the effect of intramuscularly injected botulinum toxin, we injected both extensor digitorum brevis (EDB) muscles in 13 healthy volunteers with seven varying doses of botulinum toxin type A. We measured, pre- and postinjection, EDB M-wave amplitude, area, and mean rectified voltage (MRV) (obtained during maximal voluntary muscle activation). There was a logarithmic-appearing dose-response relationship between increasing doses of botulinum toxin and decline in EDB M-wave amplitude, area, and MRV. The decline was incrementally less at higher doses of toxin and appeared to level off at a maximal effect of 85 to 90% decrement from baseline (85 to 90% "paralysis") at 15 to 20 units. The peak toxin effect was present on day 6 postinjection. Measurement of EDB M-wave amplitude, area, and MRV is a simple objective method for quantifying the onset and degree of human muscle "paralysis" following botulinum-toxin injection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8628486     DOI: 10.1212/wnl.46.5.1382

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  [Proof of botulinum toxin antibodies with the Extensor Digitorum Brevis Test].

Authors:  A Bachhuber; A Wagner; G Reichel; M Doberenz; A Stenner; W Hermann
Journal:  Nervenarzt       Date:  2008-08       Impact factor: 1.214

2.  Towards a dose optimisation of botulinum toxin therapy for axillary hyperhidrosis: comparison of different Botox(®) doses.

Authors:  Dirk Dressler; Fereshte Adib Saberi
Journal:  J Neural Transm (Vienna)       Date:  2013-06-14       Impact factor: 3.575

3.  Responsiveness to botulinum toxin type A in muscles of complex regional pain patients with tonic dystonia.

Authors:  Johanna C M Schilder; J Gert van Dijk; Dirk Dressler; Johannes H T M Koelman; Johan Marinus; Jacobus J van Hilten
Journal:  J Neural Transm (Vienna)       Date:  2014-02-15       Impact factor: 3.575

4.  Efficacy and Safety of a New Botulinum Toxin Type A Free of Complexing Proteins.

Authors:  Hyun-Mi Oh; Joo Hyun Park; Dae Heon Song; Myung Eun Chung
Journal:  Toxins (Basel)       Date:  2015-12-24       Impact factor: 4.546

Review 5.  Neurophysiological Measures of Efficacy and Safety for Botulinum Toxin Injection in Facial and Bulbar Muscles: Special Considerations.

Authors:  Mohammad Alimohammadi; Anna Rostedt Punga
Journal:  Toxins (Basel)       Date:  2017-10-30       Impact factor: 4.546

Review 6.  Over 25 Years of Pediatric Botulinum Toxin Treatments: What Have We Learned from Injection Techniques, Doses, Dilutions, and Recovery of Repeated Injections?

Authors:  Heli Sätilä
Journal:  Toxins (Basel)       Date:  2020-07-06       Impact factor: 4.546

7.  Effect of the refrigerator storage time on the potency of botox for human extensor digitorum brevis muscle paralysis.

Authors:  Mee Young Park; Ki Young Ahn
Journal:  J Clin Neurol       Date:  2013-07-01       Impact factor: 3.077

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.